Addiction
Developing the first UK parents' training programme for FASD
Fetal alcohol spectrum disorders (FASD) are the range of conditions that can be caused by prenatal alcohol exposure. Current estimates put the prevalence of FASD in the UK at around 3%, making it the most common neurodevelopmental disorder in the country; yet knowledge, understanding and services are severely lacking.
Managing Drug & Alcohol Problems in Primary Care Conference
The 25th Managing Drug and Alcohol Problems in Primary Care Conference will take place digitally on Thursday 25 and Friday 26 March 2021.
This conference will be recorded live and the sessions will be available for delegates to access freely for six months from the conference date.
James Morris: Why harmful drinkers reject change: coping and cognition in maintaining heavy drinking
Conferencias Magistrales Maestría en Gestión de Adicciones Programa
Men’s Alcohol Consumption When Becoming a Father
Scottish Health Action on Alcohol Problems (SHAAP), the Scottish Alcohol Research Network (SARN) and the Institute of Alcohol Studies (IAS) warmly invite you to join us online on Thursday 25 February from 12:30-14:00 GMT for the second Alcohol Occasionals event of 2021.
Call for Participants- UK Based Addiction Professionals
Addiction Conference 2021
Lives and livelihoods in Africa are lost every day to a medical disorder of which the true extent and severity is unknown.
Addiction needs to be seen for what it is. Not as a weakness. Not as a lack of character. Not as something that needs to be punished.
In Love with Addiction Neuroscience
In ISAM-NIG's new monthly talk series "In-Love with Addicted Brains”, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field.
Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe
This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications.